<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="associated with severe neurological complications such as Guillain–Barré syndrome and" exact="microcephaly" post="in fetuses and newborns. Although enormous efforts were made"/>
 <result pre="such as ZIKV, dengue virus (DENV), West Nile virus (WNV)," exact="yellow fever" post="virus (YFV), and Japanese encephalitis virus (JEV), have become"/>
 <result pre="West Nile virus (WNV), yellow fever virus (YFV), and Japanese" exact="encephalitis" post="virus (JEV), have become an increasing public health concern"/>
 <result pre="with severe neurological complications such as an unexpected rise of" exact="microcephaly" post="cases in fetuses and newborns and a remarkable increase"/>
 <result pre="Although 7-deaza-2-CMA inhibitor failed in human clinical trials for chronic" exact="hepatitis" post="C treatment, probably due to mitochondrial toxicity [48], this"/>
 <result pre="several viruses. In clinical trials of healthy volunteers and in" exact="influenza" post="virus-infected patients, favipiravir has been well tolerated. However, caution"/>
 <result pre="was shown to inhibit ZIKV infection and replication in human" exact="hepatocellular carcinoma" post="(Huh-7) cells, human placental choriocarcinoma (Jar) cells, and SH-Sy5y"/>
 <result pre="and replication in human hepatocellular carcinoma (Huh-7) cells, human placental" exact="choriocarcinoma" post="(Jar) cells, and SH-Sy5y neuroblastoma cells with EC50 values"/>
 <result pre="carcinoma (Huh-7) cells, human placental choriocarcinoma (Jar) cells, and SH-Sy5y" exact="neuroblastoma" post="cells with EC50 values in the range of 0.4–5"/>
 <result pre="antiviral activity against different viruses (influenza virus, DENV, coronaviruses, HIV-1," exact="hepatitis" post="B virus, etc.) [71,72,73], have been tested against NS2B-NS3"/>
 <result pre="addition, mice that survived did not present any signs of" exact="neurological disorder" post="[76]. Similarly, a study done by Yuan et al."/>
 <result pre="infection. Suramin, an anti-parasitic drug used to treat trypanosomal human" exact="sleeping sickness," post="is available for prophylactic and therapeutic use in children."/>
 <result pre="shown to inhibit multiple DNA and RNA viruses including DENV," exact="herpes simplex" post="virus type 1, cytomegaloviruses human hepatitis B, hepatitis D,"/>
 <result pre="viruses including DENV, herpes simplex virus type 1, cytomegaloviruses human" exact="hepatitis" post="B, hepatitis D, hepatitis C, bunyaviruses, enterovirus 71, and"/>
 <result pre="DENV, herpes simplex virus type 1, cytomegaloviruses human hepatitis B," exact="hepatitis" post="D, hepatitis C, bunyaviruses, enterovirus 71, and others [78,79,80,81]."/>
 <result pre="simplex virus type 1, cytomegaloviruses human hepatitis B, hepatitis D," exact="hepatitis" post="C, bunyaviruses, enterovirus 71, and others [78,79,80,81]. Suramin was"/>
 <result pre="enterovirus 71 by neutralizing virus particles prior to attachment and" exact="chikungunya" post="virus in mice [82,83,84]. Albulescu et al. showed that"/>
 <result pre="compound, was shown to abolish ZIKV replication in HeLa (cervical" exact="cancer" post="cells) and JEG3 (human choriocarcinoma cell line) cells; however,"/>
 <result pre="ZIKV replication in HeLa (cervical cancer cells) and JEG3 (human" exact="choriocarcinoma" post="cell line) cells; however, its use in pregnant women"/>
 <result pre="was suggested as a potential option to prevent GBS and" exact="microcephaly" post="[97]. Chloroquine, an anti-inflammatory FDA-approved 4-aminoquinoline, is an old"/>
 <result pre="was very effective at preventing ZIKV-induced neuronal cell death and" exact="neurodegeneration" post="in IFN-α/βR−/−mice [106]. Importantly, memantine is also listed in"/>
 <result pre="2.collab: Centers for Disease Control and Prevention (CDC)Oseltamivir-resistant 2009 pandemic" exact="influenza" post="A (H1N1) virus infection in two summer campers receiving"/>
 <result pre="sequencing of Zika virus from amniotic fluid of fetuses with" exact="microcephaly" post="in Brazil: A case studyLancet Infect. Dis.20161665366010.1016/S1473-3099(16)00095-526897108 22.MussoD.NhanT.RobinE.RocheC.BierlaireD.ZisouK.Shan YanA.Cao-LormeauV.M.BroultJ.Potential"/>
 <result pre="25.ChambersT.J.WeirR.C.GrakouiA.McCourtD.W.BazanJ.F.FletterickR.J.RiceC.M.Evidence that the N-terminal domain of nonstructural protein NS3 from" exact="yellow fever" post="virus is a serine protease responsible for site-specific cleavages"/>
 <result pre="converge within a region of 20 amino acidsJ. Virol.1999733108311610074162 28.TakegamiT.SakamuroD.FurukawaT.Japanese" exact="encephalitis" post="virus nonstructural protein NS3 has RNA binding and ATPase"/>
 <result pre="78.AguilarJ.S.RiceM.WagnerE.K.The polysulfonated compound suramin blocks adsorption and lateral difusion of" exact="herpes simplex" post="virus type-1 in vero cellsVirology199925814115110.1006/viro.1999.972310329576 79.BabaM.KonnoK.ShigetaS.WickramasingheA.MohanP.Selective inhibition of human"/>
 <result pre="Agents Chemother.2014587405741510.1128/AAC.03595-1425267680 81.WangY.QingJ.SunY.RaoZ.Suramin inhibits EV71 infectionAntivir. Res.20141031610.1016/j.antiviral.2013.12.00824374150 82.KuoS.C.WangY.M.HoY.J.ChangT.Y.LaiZ.Z.TsuiP.Y.WuT.Y.LinC.C.Suramin treatment reduces" exact="chikungunya" post="pathogenesis in miceAntivir. Res.2016134899610.1016/j.antiviral.2016.07.02527577529 83.RenP.ZouG.BaillyB.XuS.ZengM.ChenX.ShenL.ZhangY.GuillonP.Arenzana-SeisdedosF.et al.The approved pediatric drug"/>
</results>
